跳至主要内容
临床试验/NCT05920330
NCT05920330招募中不适用

Novel Mechanisms and Therapeutic Approaches for Nasal Obstruction and Olfactory Losses

Ohio State University1 个研究点 分布在 1 个国家目标入组 330 人开始时间: 2023年1月25日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
入组人数
330
试验地点
1
主要终点
Change in Nasal Obstruction Symptom Evaluation (NOSE) questionnaire

研究概览

简要总结

About 13% of US adults, some 30 million people, suffer from nasal sinus disease. Although nasal obstruction and smell loss are two of the major symptoms of the disease that are crucial to disease management, currently there is a lack of clinical tools to effectively evaluate the mechanisms contributing to these symptoms. The proposed study aims to develop novel clinical tools to better evaluate and relieve patients' nasal obstructive symptoms and to enable patients and clinicians to make more informed, personalized decisions regarding treatment strategy.

详细描述

Nasal sinus disease is one of the most common medical conditions in the US, affecting an estimated 13% of adults, or some 30 million people, and responsible for $5.8 billion in health care expenditures annually (National Health Interview Survey 2009, CDC). Nasal obstruction and smell loss are two of the major symptoms of the disease; however, the field currently lacks a clear, objective understanding of the mechanisms causing these symptoms, which thwarts effective treatment. For example, patients' complaints of nasal obstruction correlate poorly or inconsistently with objective measurements of actual physical obstruction. Without validated clinical tools, the current treatment of these symptoms relies primarily on the patient's subjective feedback and the doctor's personal training and experience, which can lead to inconsistent and unsatisfactory outcomes.

Through a series of preliminary studies, the investigators demonstrated that the symptom of nasal obstruction may be caused not by obstruction per se but by poor sensing of airflow during breathing or sensing may be worsened by impaired trigeminal function. However, which trigeminal sensory regions and what nasal airflow anomalies are most critical in disrupting the sensing of airflow are still unknown. In Aim 2, the investigators will investigate the efficacy of a novel patent-pending "nasal aid" to improve patients' symptoms by modulating nasal airflow and trigeminal sensory feedback and to improve future treatment outcomes based on what the investigators have learned and will continue to learn about the airflow trigeminal perception mechanisms.

The outcomes from this research may potentially validate several novel clinical tools to better identify factors that most affect patients' obstructive symptoms and to relieve symptoms by modulating nasal airflow patterns. The ultimate goal is to assist patients and clinicians in planning effective, well-informed, personalized treatment strategies, potentially saving millions of healthcare dollars annually while improving patient satisfaction.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者
是

入选标准

  • •Smell Loss complaints
  • •Nasal Obstruction

排除标准

  • •Congenital olfactory losses
  • •Nasal polyps, blocking the olfactory cleft
  • •Significant atrophy
  • •Cystic fibrosis
  • •Wegeners or any other connective tissue disorder
  • •Head trauma

研究组 & 干预措施

Single Arm

Other

A device-nasal plug will be self-inserted into the nose with a diagonal channel embedded to redirect nasal airflow patterns to different nasal regions. A nose clip will be used to pinch the nose externally, similar to what synchronized swimmers use.

干预措施: Nasal Plug (Other)

结局指标

主要结局

Change in Nasal Obstruction Symptom Evaluation (NOSE) questionnaire

时间窗: 3 time points: 1-baseline, 2-after the applications of nasal aid (done on the first day of testing), and 3- 8 weeks after surgery.

A clinically validated 5 item questionnaire to document general nasal obstruction. symptoms severity.

Change in Visual Analog Scale (VAS) of nasal obstruction

时间窗: 3 time points:1-baseline, 2-after the applications of nasal aid (done on the first day of testing) and 3-8 weeks after surgery.

A visual analog scale of nasal obstruction (VAS), with ratings from 0 to 10 (0 = completely clear; 10 = completely obstructed).

Change in Empty Nose Syndrome 6-Item Questionnaire (ENS 6 Q)

时间窗: 3 time points:1-baseline, 2-after the applications of nasal aid (done on the first day of testing) and 3-8 weeks after surgery.

A validated ENS-specific symptom questionnaire.

次要结局

  • Change in Sino-nasal Outcome Test (SNOT-22)(1-baseline (done on the first day of testing)and 2- 8 weeks after surgery)
  • Change in rhinomanometry(1-Baseline (done on the first day of testing) and 2- 8 weeks post-surgery)
  • Change in nasal resistance(1-baseline (done on the first day of testing) and 2- 8 weeks after surgery)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Kai Zhao

Associate Professor

Ohio State University

研究点 (1)

Loading locations...

相似试验